Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study
Titel:
Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study
Auteur:
Dobesh, Paul P. Fermann, Gregory J. Christoph, Mary J. Koch, Bruce Lesén, Eva Chen, Hungta Lovelace, Belinda Dettling, Theresa Danese, Mark Ulloa, Julie Danese, Sherry Coleman, Craig I.
Verschenen in:
Research and practice in thrombosis and haemostasis